版本:
中国

BRIEF-Asterias publishes positive Phase 2 data on AST-VAC1 for the treatment of acute myeloid leukemia

April 26 Asterias Biotherapeutics Inc

* Asterias announces publication of positive Phase 2 data on AST-VAC1 for the treatment of acute myeloid leukemia (AML) in 'cancer'

* Asterias Biotherapeutics Inc - AST-VAC1 was found to be safe and well-tolerated in this study over multiple vaccinations Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐